Excessive levels of GABA released by astrocytes impair the brain's ability to extinguish fear responses in PTSD, but a newly ...

Researchers integrated machine learning with multi-tiered validation to identify FDA-approved non-lipid-lowering drugs with lipid-modifying potential. From 3,430 drugs screened, 29 candidates emerged.

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in both.

The cancellation of hundreds of National Institutes of Health grants by the Trump administration this year left the project ...

IMUNON, Inc. (IMNN) said on Wednesday its first patient has been dosed with the firm’s lead candidate, IMNN-001, as part of a ...

AbbVie shares promising phase 3 results for Rinvoq in treating severe alopecia areata, with significant hair regrowth ...

In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid ...

Zou is a pioneering AI researcher who has been recognized widely for breakthroughs in using AI for biomedical research, ...

A drug from Fulcrum Therapeutics showed promise in a sickle cell study, raising the possibility that a pill could be an ...

Model considers two DM particles, one stable and one unstable, as well as a vector mediator similar to the photon but with mass, which would promote interaction with ordinary matter particles.

AI-based simulation models are poised to help cell biologists cut costs, ask smarter questions, and do more with less.

In a revealing Genomic Press Interview published today in Brain Medicine, Dr. Camilo de la Fuente-Sandoval shares how ...